Arturo Loaiza-Bonilla, MD, MSEd, FACP, explains the basic scientific concepts behind neuroendocrine tumors (NETs), as well as classifying and staging these cancers. He then discusses the rationale behind targeting somatostatin receptors in NETs, therapy options, and future research in this setting.Read More
Arturo Loaiza-Bonilla, MD, MSEd, FACP
Cancer Treatment Centers of America
Board certified in medical oncology as well as hematology, Dr. Loaiza-Bonilla is dedicated to comprehensive care for patients suffering from gastrointestinal malignancies, such as colon, esophagus, gastric, liver, pancreas and neuroendocrine tumors. Dr. Loaiza-Bonilla earned a medical degree from the Universidad Nacional de Colombia in Bogotá, Colombia. Following medical school, he completed an internship and residency in internal medicine at Harbor Hospital Center, Johns Hopkins Hospital in Baltimore, Maryland. Dr. Loaiza-Bonilla also completed a fellowship in hematology and oncology from the University of Miami, Miller School of Medicine in Miami, Florida. Prior to joining CTCA, Dr. Loaiza-Bonilla was an assistant professor of clinical medicine at the Perelman School of Medicine at the University of Pennsylvania. During this time, he completed his master’s degree in medical education at the same university. Dr. Loaiza-Bonilla has been published in several medical journals and oncology publications. He is also a reviewer and counselor for several journals, special interest groups, panels and academic competitions. He has also served as principal investigator and co-investigator for many large oncology clinical trials. Dr. Loaiza-Bonilla has been a member and held leadership positions for several medical organizations. These include the Pennsylvania Society of Oncology and Hematology, American Society of Hematology, American Society of Clinical Oncology and American Association of Cancer Research.